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E-mail address: fwalsh@staffmail.eSummary Pseudomonas aeruginosa with decreased levels of meropenem
susceptibility were identified in the Royal Infirmary Edinburgh in 2002.
Within the affected group of patients, none had meropenem-resistant P.
aeruginosa when they arrived in the intensive care unit (ICU). Seven isolates
from the ICU were collected five months after the decreased susceptibility
to meropenem was identified. In order to investigate if resistance was a
problem in P. aeruginosa throughout Edinburgh, both in hospital- and
community-acquired isolates, a prospective study was performed. The
susceptibilities of 104 P. aeruginosa to imipenem,meropenem, ceftazidime,
piperacillin/tazobactam and ciprofloxacin were investigated. Meropenem
had the highest activity against these isolates and the lowest MIC90 (2 mg/L),
followed by imipenem (4 mg/L), ciprofloxacin (8 mg/L), piperacillin/tazo-
bactam (16 mg/L) and ceftazidime (32 mg/L). These isolates were also
analysed genotypically by pulsed-field gel electrophoresis. Five of the seven
ICU isolates were identified, one isolate was 98% similar and the other was
85% similar to the ICU isolates. One isolate from the prospective study had
approximately 90% genotype similarity to the six ICU isolates with R98%
similarity. There was no clonality within the strains from the prospective
study and clusters with O90% similarity comprised at five or less isolates.
Isolates with the same resistance patterns did not necessarily have the same
genotypic profile. Strains isolated from different patients on the same day
were also not necessarily related. The conclusions of this study were that
while the seven ICU isolates were clonal or highly related, they were not
widespread throughout Edinburgh and the P. aeruginosa within Edinburgh
were highly varied.
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Table I Susceptibility profiles of the outbreak isolates
Strain ID Imipenem MIC
(mg/L)
Meropenem MIC
(mg/L)
Ceftazidime MIC
(mg/L)
Piperacillin/
tazobactam MIC
(mg/L)
Ciprofloxacin MIC
(mg/L)
O1 16 R 16 R 4 32 R 16 R
O2 8 R 4 32 R 8 8 R
O3 4 4 2 4 8 R
O4 2 0.5 4 4 0.12
O5 4 8 R 2 8 16 R
O6 0.5 0.25 2 4 8 R
O7 4 8 R 2 8 16 R
R, resistant; MIC, minimum inhibitory concentration.
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Pseudomonas aeruginosa is the second most fre-
quently reported pathogen overall in intensive-
care-unit (ICU)-acquired infections in Europe.1 It is
of particular concern for intubated and/or immu-
nocompromised patients. The antimicrobial agents
most commonly used to treat P. aeruginosa infec-
tions are meropenem, imipenem, ceftazadime,
piperacillin/tazobactam and ciprofloxacin. How-
ever, resistance to imipenem is increasing; in
recent years, it has increased to between 12% and
18%.1 Resistance to other therapeutic agents varied
from 9.8% for meropenem to 25% for ciprofloxacin.
There is an awareness of the ever-decreasing
number of available therapeutic options. There-
fore, it is important to understand the origins of
resistance in order to minimize its transmission and
spread. When an outbreak of resistant isolates
occurs within a hospital, it is important to under-
stand whether the outbreak is caused by a single
clone or multiple isolates, and whether they have
resistance to all available antimicrobial agents or
specifically to one antimicrobial agent. There are
various techniques available to analyse similarity or
diversity of bacterial isolates. Pulsed-field gel
electrophoresis (PFGE) is one such method, which
is preferred to other typing methods by many
laboratories for the epidemiological study of
bacteria, such as P. aeruginosa.2
The aims of this study were firstly to identify
whether resistant P. aeruginosa were widespread in
hospitals and the community in Edinburgh. Sec-
ondly, as resistance in the ICU appeared within
days, we decided to analyse the Edinburgh cohort
genotypically to investigate whether there was a
clonal relationship between P. aeruginosa with the
same and different resistance patterns, i.e. to
elucidate whether sensitive isolates were of the
same genotype as resistant isolates, and toinvestigate whether there was a genotypic link
between hospital- and community-acquired P.
aeruginosa.Materials and methods
Bacterial strains and susceptibility testing
Seven resistant P. aeruginosa isolates from the ICU
with the initial meropenem resistance problem
were collected in December and early January of
2002 and 2003, respectively. These isolates were
identified as meropenem resistant by the Royal
Infirmary Edinburgh. One hundred and four P.
aeruginosa strains, 23 from community-acquired
infections and 81 from hospital-acquired infections,
identified by the diagnostic laboratories at the
Royal Infirmary Edinburgh were collected between
January and May 2003. The antimicrobial agents
were obtained from their respective manufacturers
and were stored and prepared according to the
manufacturers’ guidelines. The susceptibilities of
the P. aeruginosa to imipenem, meropenem,
ceftazidime, piperacillin/tazobactam and cipro-
floxacin were determined by agar dilution in vitro,
according to the British Society for Antimicrobial
Chemotherapy (BSAC) guidelines.3 The antimicro-
bial breakpoints were assigned at the following
minimum inhibitory concentration (MIC) values
according to the BSAC guidelines: imipenem
R8 mg/L; meropenem R8 mg/L; ceftazidime
R16 mg/L; piperacillin/tazobactam R32 mg/L;
and ciprofloxacin R2 mg/L.4PFGE analysis
All isolates were genotyped by PFGE (CHEF DR II
system, BioRad, Hemel Hempstead, Hertfordshire,
UK) following total bacterial DNA digestion with the
Table II Susceptibility profiles of the 104 prospec-
tive study isolates
Antimicrobial
agents
Range
(mg/L)
MIC50
(mg/L)
MIC90
(mg/L)
Imipenem 0.5–32 2 4
Meropenem 0.032–16 0.25 2
Ceftazidime 0.5–32 2 32
Piperacillin/
tazobactam
0.5–128 4 16
Ciprofloxacin 0.016–32 0.25 8
MIC, minimum inhibitory concentration.
F. Walsh et al.242endonuclease Xba I. The method of Cheng et al. was
used with the following alteration: a suspension of a
single colony of each isolate was made in buffer
(4.38% NaCl, 9.3% EDTANa2, 86.32% distilled water)
and mixed with molten 1% low-melting-pointTable III Clustered susceptibility profiles of the 104 prosp
Isolate Imipenem MIC
(mg/L)
Meropenem MIC
(mg/L)
Cef
PaFW 46 32 R 4
PaFW 10 2 0.25
PaFW 14 16 R 16 R
PaFW 50 4 0.5
PaFW 110 16 R 16 R
PaFW 3 2 1
PaFW 19 1 2
PaFW 21 2 0.5
PaFW 29 16 R 4
PaFW 65 1 0.12
PaFW 95 8 R 4
PaFW 7 1 2
PaFW 16 1 0.5
PaFW 23 0.5 0.25
PaFW 24 2 1
PaFW 25 2 2
PaFW 26 1 0.25
PaFW 34 1 0.5
PaFW 37 4 2
PaFW 59 0.5 0.032
PaFW 60 4 0.25
PaFW 61 2 0.5
PaFW 62 2 1
PaFW 63 2 0.25
PaFW 71 2 0.25
PaFW 80 4 0.12
PaFW 85 2 0.12
PaFW 93 32 R 4
PaFW 102 2 0.5
PaFW 108 4 0.25
PaFW 111 2 0.25
R, resistant; MIC, minimum inhibitory concentration.preparative-grade agarose instead of overnight
broth culture.5 The macrorestriction patterns were
compared by Bionumericsw software (Applied Maths,
Sint-Martens-Latem, Belgium). The percent related-
ness was calculated using the Dice coefficient, and
the unweighted pair group method with arithmetic
averages was used for cluster analysis to produce a
dendogram with band optimization settings of 1.00%
and a band tolerance position of 1.0–2.0%.Results
Phenotypic characteristics
The susceptibility profiles of the seven outbreak
isolates are shown in Table I.
The prospective study had the following rates ofective study isolates
tazidime MIC
(mg/L)
Piperacillin/
tazobactam MIC
(mg/L)
Ciprofloxacin MIC
(mg/L)
32 R 32 R 2 R
32 R 64 R 8 R
8 16 8 R
32 R 32 R 4 R
2 4 8 R
32 R 4 32 R
32 R 4 32 R
32 R 32 R 0.12
32 R 4 0.12
32 R 128 R 1
8 16 2 R
32 R 8 1
4 16 32 R
2 4 8 R
32 R 4 0.12
32 R 16 0.5
8 16 4 R
32 R 8 0.25
2 4 8 R
1 0.5 2 R
2 0.5 2 R
8 4 2 R
16 R 4 1
4 8 8 R
2 4 4 R
4 8 8 R
2 4 4 R
1 2 0.12
8 8 16 R
16 R 16 0.25
2 4 4 R
Figure 1 Cluster analysis dendogram of Pseudomonas aeruginosa isolates showing the percent similarities and
resistance profiles of the isolates.
Epidemiology of P. aeruginosa 243resistance: ciprofloxacin 20%; ceftazidime 13.5%;
imipenem 5.8%; piperacillin/tazobactam 4.8%; and
meropenem 1.9%. The MIC range, MIC50 and MIC90 of
meropenem was the lowest of the five antimicrobial
agents against the 104 isolates as indicated in Table II.
The isolates were numbered in the order inwhich they
were collected, i.e. PaFW 1 was the isolate collected
first. The MICs for each cluster of isolates against the
five antimicrobial agents are described in Table III.PFGE analysis
PFGE analysis of all of the isolates showed rates ofsimilarity from 52% to 100% on the dendogram using
the BioNumerics software analysis (Figure 1). Most
of the isolates had O75% similarity. Five of the
seven initial isolates had 100% similarity, one
isolate was 98% similar and the other was 85%
similar to the other outbreak isolates. Isolate PaFW
62 had approximately 90% genotype similarity to
the six outbreak isolates with similarities ofR98%.
These seven isolates formed the only major cluster
of the isolates genotyped. No other cluster had
comparable percent similarities. While most of the
isolates had O75% similarity, clusters with O90%
similarity contained at five or less isolates. Within
F. Walsh et al.244these small groups, the isolates were not necess-
arily isolated at the same time; PaFW 9, PaFW 47
and PaFW 76 had 90% similarity. Isolates with the
same patterns of resistance were also not clustered
together. There was no genotypic similarity pattern
to suggest that resistant or susceptible isolates
have spread from the community to the hospital or
vice versa. There was also little similarity to the
outbreak isolates; the sequence similarity of the
104 prospective study isolates was!82% similar to
the outbreak isolates.Discussion
This study provides the first published data on the
genetic relatedness of hospital isolates of P.
aeruginosa resistant to antibacterial agents and
susceptible P. aeruginosa from different and the
same sites of isolation in the UK. PFGE has been
shown to be an excellent epidemiological tool for
the discrimination of related and unrelated isolates
of P. aeruginosa.6,7 Tenover et al. defined cat-
egories of genetic and epidemiological relatedness
of isolates using PFGE.8 However, they suggested
that these guidelines should be used to examine
relatively small sets of isolates (typically %30)
related to putative outbreaks of disease. There-
fore, these guidelines were not used to analyse the
111 isolates of this study.
The results of this study have shown that only
seven of the isolates were closely related, six of
which were associated with the outbreak and one
was a non-outbreak isolate. One of the outbreak
isolates was genetically distinct from the others.
This indicates that while the outbreak was most
probably caused by one clone, at least one other
type of strain/clone was also involved. These
isolates also had varying resistance profiles. The
reasons for this could be that either the resistance
associated with the original clone was modified as
the selective pressure of the antimicrobial agent
was removed, or isolates with the same genetics
had different resistance mechanisms. All the
isolates had a level of relatedness associated as
being part of the same species, but were not
related to such an extent that they were clonal.
Therefore, the outbreak did not persist and normal
infection control measures have eradicated the
problem.No clonality existed within either the resistant or
sensitive P. aeruginosa isolated. This study suggests
that none of the genotypes present were predis-
posed to the acquisition of resistance genes, nor did
one type persist more than the others. Thus, there
has not been a specific type or clone that has
established itself within Edinburgh. The conclusions
of this study were that while the outbreak isolates
were clonal or highly related, they did not persist or
spread to other areas within Edinburgh, as indicated
by the prospective study. The prospective study
isolates were very heterogeneous and resistant
clones were not selected from the strains within
this environment.Acknowledgements
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